SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-14-002240
Filing Date
2014-04-08
Accepted
2014-04-08 17:30:19
Documents
8

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT posam2014a1_soligenix.htm POS AM 1777492
2 CONSENT OF EISNERAMPER LLP posam2014a1ex23i_soligenix.htm EX-23.1 2643
  Complete submission text file 0001213900-14-002240.txt   7539782

Data Files

Seq Description Document Type Size
3 XBRL sngx-20131231.xml EX-101.INS 1025049
4 XBRL sngx-20131231.xsd EX-101.SCH 49597
5 XBRL sngx-20131231_cal.xml EX-101.CAL 35218
6 XBRL sngx-20131231_def.xml EX-101.DEF 189786
7 XBRL sngx-20131231_lab.xml EX-101.LAB 447393
8 XBRL sngx-20131231_pre.xml EX-101.PRE 329658
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-192908 | Film No.: 14751970
SIC: 2834 Pharmaceutical Preparations